학술논문

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants
Document Type
article
Author
Barnes, Daniel RRookus, Matti AMcGuffog, LesleyLeslie, GoskaMooij, Thea MDennis, JoeMavaddat, NasimAdlard, JulianAhmed, MunazaAittomäki, KristiinaAndrieu, NadineAndrulis, Irene LArnold, NorbertArun, Banu KAzzollini, JacopoBalmaña, JudithBarkardottir, Rosa BBarrowdale, DanielBenitez, JavierBerthet, PascalineBiałkowska, KatarzynaBlanco, Amie MBlok, Marinus JBonanni, BernardoBoonen, Susanne EBorg, ÅkeBozsik, AnikoBradbury, Angela RBrennan, PaulBrewer, CaroleBrunet, JoanBuys, Saundra SCaldés, TrinidadCaligo, Maria ACampbell, IanChristensen, Lise LotteChung, Wendy KClaes, Kathleen BMColas, ChrystelleCollonge-Rame, Marie-AgnèsCook, JackieDaly, Mary BDavidson, Rosemariede la Hoya, Miguelde Putter, RobinDelnatte, CapucineDevilee, PeterDiez, OrlandDing, Yuan ChunDomchek, Susan MDorfling, Cecilia MDumont, MartineEeles, RosEjlertsen, BentEngel, ChristophEvans, D GarethFaivre, LaurenceForetova, LenkaFostira, FlorentiaFriedlander, MichaelFriedman, EitanFrost, DebraGanz, Patricia AGarber, JudyGehrig, AndreaGerdes, Anne-MarieGesta, PaulGiraud, SophieGlendon, GordGodwin, Andrew KGoldgar, David EGonzález-Neira, AnnaGreene, Mark HGschwantler-Kaulich, DaphneHahnen, EricHamann, UteHanson, HelenHentschel, JuliaHogervorst, Frans BLHooning, Maartje JHorvath, JuditHu, ChunlingHulick, Peter JImyanitov, Evgeny NIsaacs, ClaudineIzatt, LouiseIzquierdo, AngelJakubowska, AnnaJames, Paul AJanavicius, RamunasJohn, Esther MJoseph, VijaiKarlan, Beth YKast, KarinKoudijs, MarcoKruse, Torben AKwong, AvaLaitman, YaelLasset, ChristineLazaro, Conxi
Source
Genetics in Medicine. 22(10)
Subject
Clinical Research
Cancer
Ovarian Cancer
Prevention
Rare Diseases
Breast Cancer
2.1 Biological and endogenous factors
Aetiology
BRCA1 Protein
BRCA2 Protein
Breast Neoplasms
Carcinoma
Ovarian Epithelial
Female
Genetic Predisposition to Disease
Heterozygote
Humans
Mutation
Ovarian Neoplasms
Prospective Studies
Retrospective Studies
Risk Factors
BRCA1
2
breast cancer
ovarian cancer
PRS
genetics
GEMO Study Collaborators
EMBRACE Collaborators
kConFab Investigators
HEBON Investigators
GENEPSO Investigators
Consortium of Investigators of Modifiers of BRCA and BRCA2
BRCA1/2
Genetics
Clinical Sciences
Genetics & Heredity
Language
Abstract
PurposeWe assessed the associations between population-based polygenic risk scores (PRS) for breast (BC) or epithelial ovarian cancer (EOC) with cancer risks for BRCA1 and BRCA2 pathogenic variant carriers.MethodsRetrospective cohort data on 18,935 BRCA1 and 12,339 BRCA2 female pathogenic variant carriers of European ancestry were available. Three versions of a 313 single-nucleotide polymorphism (SNP) BC PRS were evaluated based on whether they predict overall, estrogen receptor (ER)-negative, or ER-positive BC, and two PRS for overall or high-grade serous EOC. Associations were validated in a prospective cohort.ResultsThe ER-negative PRS showed the strongest association with BC risk for BRCA1 carriers (hazard ratio [HR] per standard deviation = 1.29 [95% CI 1.25-1.33], P = 3×10-72). For BRCA2, the strongest association was with overall BC PRS (HR = 1.31 [95% CI 1.27-1.36], P = 7×10-50). HR estimates decreased significantly with age and there was evidence for differences in associations by predicted variant effects on protein expression. The HR estimates were smaller than general population estimates. The high-grade serous PRS yielded the strongest associations with EOC risk for BRCA1 (HR = 1.32 [95% CI 1.25-1.40], P = 3×10-22) and BRCA2 (HR = 1.44 [95% CI 1.30-1.60], P = 4×10-12) carriers. The associations in the prospective cohort were similar.ConclusionPopulation-based PRS are strongly associated with BC and EOC risks for BRCA1/2 carriers and predict substantial absolute risk differences for women at PRS distribution extremes.